24.100
+14,76%
2026-10-13
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +7.8% | +12.3% | 3 / 3 | -0.6% | -0.91 pp | +0.92 pp | +28.4% | 0.00 | 5.31 | 226 | −0,6% | 26,7 | +7,8% | 5.31 | 8.81 | −39,8% |
| Pts | 0 | 0 | 12 | 0 | 4 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 24.100 (close price on 2026-10-13)EPS (TTM): 4.542
Financial charts
1.Revenue & growth
VND bn226Q2/26
1.Revenue & growth
VND bn226Q2/26
2.Profit & growth
VND bn26,8Q2/26
3.Profit mix (Penman)
VND bn101Q2/26
4.Margins & cost structure
%22.5%Q2/26
5.Returns & cash cycle
% · days259%Q2/26
6.Earnings quality & cash
VND bn47,3Q2/26
7.Asset structure
VND bn629Q2/26
8.Funding & debt health
VND bn · times629Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %5,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.376Q2/26
Adjusted EPS growth, latest quarter
8.4%
Average adjusted EPS growth, 3 quarters
12.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26